ランキング
価格
はじめての方へ
ログイン
無料体験
米国企業
Arcutis Biotherapeutics, Inc.
Arcutis Biotherapeutics, Inc.
ARQT
時価総額
$9.9億
PER
マイリストに追加
マイリストに追加
サマリーテーブルに戻る
十億
百万
千
USD
年次
四半期
Download CSV
損益計算書
バランスシート
キャッシュフロー
2023年
12月31日
Net loss
-262
Depreciation
1
Non-cash lease expense
0
Amortization of intangible assets
1
Net amortization/accretion on marketable securities
7
Accretion Expense
4
Stock-based compensation
39
Change in fair value of embedded derivative instrument
-1
Accounts receivable, net
17
Inventories
6
Prepaid expenses and other current assets
9
Accounts payable
3
Accrued liabilities
6
Operating lease liabilities
-1
Net cash used in operating activities
-247
Purchases of marketable securities
226
Proceeds from maturities of marketable securities
407
Purchases of property and equipment
0
Net cash provided by (used in) investing activities
180
Proceeds from Stock Options Exercised
1
Proceeds from issuance of shares under ATM, net of issuance costs
3
Proceeds from issuance of common stock and pre-funded warrants, net of issuance costs
96
Proceeds from issuance of common stock for ESPP
1
Net cash provided by financing activities
101
Effect of exchange rate changes on cash
-0
Net increase (decrease) in cash, cash equivalents and restricted cash
34
Interest expense paid in cash
25